Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
345.00    0.00 (0.00%)
Bid:
330.00
Ask:
360.00
Spread: 30.00 (9.091%)
Market Cap: £32.96m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

PDMR and PCA Shareholding

3 Feb 2025 07:00

RNS Number : 5467V
Cropper(James) PLC
03 February 2025
 

James Cropper plc

(the "Company")

 

PDMR and PCA Shareholding

 

The Company has been notified that, on 31 January 2025, Mark Cropper (Non-Executive Chair) transferred 5,000 ordinary shares of 25p each ("Shares") in the Company to his son, James Cropper, for a consideration of £1.975 per Share.

 

In addition, following a change in age, the Company has been notified that 26,349 Shares in the Company previously reported within Mark Cropper's beneficial ownership have now transferred to the beneficial ownership of his son, James Cropper.

 

Following the above changes, the beneficial interests of Mark Cropper and his son, James Cropper, in the Company's share capital are as follows:

 

Shareholding

Mark Cropper

James Cropper

No. Shares

% share capital*

No. Shares

% share capital*

Beneficial

1,895,977

19.8

31,349

0.33

Non-beneficial

559,571

5.9

0

0

Total

2,455,548

26.0

31,349

0.33

*based on the Company's current issued Share capital of 9,554,803 Shares

 

Mark Cropper and members of the Cropper, Willink and Acland families are deemed to act in concert and are regarded by the Takeover Panel as being members of a concert party as detailed in the Company's circular to shareholders dated 30 June 2015 (the "Concert Party"). The Concert Party has a collective interest in 3,624,109 Ordinary Shares representing 37.9% of the Company's issued share capital.

Enquiries

 

James Cropper plc

Matt Ratcliffe, General Counsel and Company Secretary

Tel: +44 (0) 1539 722 002

 

Shore Capital - (NOMAD and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0) 7601 6100

 

Buchanan Communications - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

 

 

 

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

1.

Details of person discharging managerial responsibilities/person closely associated

 

a)

Name

(i) Mark Cropper

(ii) James Cropper

2.

 

Reason for the notification

a)

Position/status

(i) Mark Cropper: Non-Executive Chair

(ii) James Cropper: PCA of Mark Cropper

b)

Initial notification/amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

James Cropper plc

 

b)

Legal Entity Identifier

213800XM78VTDYGBRM93

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the

financial instrument

Ordinary Shares of 25 pence each

b)

Identification code of the Financial Instrument

GB0002346053

c)

Nature of the

transaction

(i) Sale of 5,000 Shares by Mark Cropper to James Cropper

(ii) Transfer of 26,349 Shares by Mark Cropper to James Cropper

d)

Currency

GBP

 

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

(i)

£1.975 per Share

5,000

(ii)

Nil

26,349

 

f)

Aggregated

information

- volume

- Price

- Total

 

 

 

(i) Volume: 5,000

(i) Price: £1.975

(i) Total: £9,875

 

(ii) Volume: 26,349

(ii) Price: Nil

(ii) Total: N/A

 

g)

Date of the transaction

31.01.2025

h)

Place of the transaction

Off market

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDIFWFEISELF
Date   Source Headline
9th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSHalf-year Report
4th Nov 20217:00 amRNSDirectorate Change
24th Sep 20211:44 pmRNSDirector/PDMR Shareholding
9th Sep 20215:35 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSGrant of Awards under Long Term Incentive Plan
5th Aug 20217:00 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 202111:00 amRNSAGM Statement and Trading Update
27th Jul 202110:27 amRNSDirector/PDMR Shareholding
23rd Jul 20219:52 amRNSDirector/PDMR Shareholding
23rd Jul 20217:00 amRNSUpdate for visitors to the AGM
21st Jul 20217:00 amRNSDirector/PDMR Shareholding
6th Jul 20217:46 amRNSDirector/PDMR Shareholding
1st Jul 20212:30 pmRNSHolding(s) in Company
22nd Jun 20218:36 amRNSDirectorate Change
22nd Jun 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSDirector Dealing
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20219:31 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSAcquisition
18th Dec 202011:05 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20202:06 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSHalf-year Report
5th Aug 20207:00 amRNSGrant of Awards under Long Term Incentive Plan
31st Jul 20207:00 amRNSDirector/PDMR Shareholding
30th Jul 20209:41 amRNSResult of AGM
29th Jul 20207:00 amRNSAGM Statement and Trading Update
27th Jul 20201:47 pmRNSDirector/PDMR Shareholding
27th Jul 20209:00 amRNSDirectorate Change
23rd Jun 20207:00 amRNSFinal Results
1st May 20207:00 amRNSYear end and COVID 19 trading update
24th Mar 20203:57 pmRNSCOVID 19 update
20th Feb 20209:45 amRNSDirector Dealing
14th Feb 202010:13 amRNSDirector Dealing
30th Jan 20208:55 amRNSDirector/PDMR Shareholding
24th Jan 20204:30 pmRNSDirector/PDMR Shareholding
21st Jan 20202:00 pmRNSHolding(s) in Company
13th Jan 202011:05 amRNSDirector/PDMR Shareholding
17th Dec 201912:24 pmRNSDirector/PDMR Shareholding
13th Dec 20197:00 amRNSDirectors' Dealings
29th Nov 201910:42 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings
9th Aug 20197:00 amRNSNotification of Transaction of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.